nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Pemetrexed—lung cancer	0.34	0.735	CbGbCtD
Emtricitabine—Lamivudine—Gemcitabine—lung cancer	0.193	0.446	CrCrCtD
Emtricitabine—Zalcitabine—Gemcitabine—lung cancer	0.167	0.386	CrCrCtD
Emtricitabine—DCK—Gemcitabine—lung cancer	0.123	0.265	CbGbCtD
Emtricitabine—Decitabine—Gemcitabine—lung cancer	0.0724	0.168	CrCrCtD
Emtricitabine—DCK—Topotecan—Irinotecan—lung cancer	0.00176	0.821	CbGdCrCtD
Emtricitabine—Floxuridine—TYMS—lung cancer	0.00109	0.479	CrCbGaD
Emtricitabine—Lamivudine—ABCC3—lung cancer	0.000701	0.309	CrCbGaD
Emtricitabine—DCK—Epirubicin—Doxorubicin—lung cancer	0.000382	0.179	CbGdCrCtD
Emtricitabine—Lamivudine—ABCG2—lung cancer	0.00034	0.15	CrCbGaD
Emtricitabine—Lamivudine—ABCB1—lung cancer	0.000142	0.0624	CrCbGaD
Emtricitabine—Nausea—Vinblastine—lung cancer	6.59e-05	0.000652	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Irinotecan—lung cancer	6.56e-05	0.000649	CcSEcCtD
Emtricitabine—Fatigue—Irinotecan—lung cancer	6.55e-05	0.000648	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	6.55e-05	0.000648	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—lung cancer	6.53e-05	0.000646	CcSEcCtD
Emtricitabine—Pruritus—Vinorelbine—lung cancer	6.52e-05	0.000645	CcSEcCtD
Emtricitabine—Pain—Irinotecan—lung cancer	6.5e-05	0.000643	CcSEcCtD
Emtricitabine—Mental disorder—Docetaxel—lung cancer	6.48e-05	0.000641	CcSEcCtD
Emtricitabine—Arthralgia—Paclitaxel—lung cancer	6.46e-05	0.00064	CcSEcCtD
Emtricitabine—Myalgia—Paclitaxel—lung cancer	6.46e-05	0.00064	CcSEcCtD
Emtricitabine—Anxiety—Paclitaxel—lung cancer	6.44e-05	0.000637	CcSEcCtD
Emtricitabine—Malnutrition—Docetaxel—lung cancer	6.44e-05	0.000637	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	6.42e-05	0.000635	CcSEcCtD
Emtricitabine—Nausea—Topotecan—lung cancer	6.4e-05	0.000633	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Gemcitabine—lung cancer	6.39e-05	0.000632	CcSEcCtD
Emtricitabine—Fatigue—Gemcitabine—lung cancer	6.38e-05	0.000631	CcSEcCtD
Emtricitabine—Pain—Gemcitabine—lung cancer	6.33e-05	0.000626	CcSEcCtD
Emtricitabine—Nausea—Erlotinib—lung cancer	6.33e-05	0.000626	CcSEcCtD
Emtricitabine—Diarrhoea—Vinorelbine—lung cancer	6.3e-05	0.000624	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Cisplatin—lung cancer	6.29e-05	0.000622	CcSEcCtD
Emtricitabine—Infection—Etoposide—lung cancer	6.28e-05	0.000621	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—lung cancer	6.25e-05	0.000618	CcSEcCtD
Emtricitabine—Back pain—Docetaxel—lung cancer	6.23e-05	0.000616	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—lung cancer	6.23e-05	0.000616	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Irinotecan—lung cancer	6.21e-05	0.000615	CcSEcCtD
Emtricitabine—Paraesthesia—Cisplatin—lung cancer	6.19e-05	0.000613	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—lung cancer	6.19e-05	0.000612	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—lung cancer	6.19e-05	0.000612	CcSEcCtD
Emtricitabine—Infection—Paclitaxel—lung cancer	6.16e-05	0.000609	CcSEcCtD
Emtricitabine—Dyspnoea—Cisplatin—lung cancer	6.15e-05	0.000609	CcSEcCtD
Emtricitabine—Skin disorder—Etoposide—lung cancer	6.14e-05	0.000608	CcSEcCtD
Emtricitabine—Dizziness—Vinorelbine—lung cancer	6.09e-05	0.000603	CcSEcCtD
Emtricitabine—Nervous system disorder—Paclitaxel—lung cancer	6.08e-05	0.000601	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—lung cancer	6.07e-05	0.000601	CcSEcCtD
Emtricitabine—Thrombocytopenia—Paclitaxel—lung cancer	6.07e-05	0.0006	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—lung cancer	6.03e-05	0.000596	CcSEcCtD
Emtricitabine—Skin disorder—Paclitaxel—lung cancer	6.02e-05	0.000596	CcSEcCtD
Emtricitabine—Body temperature increased—Irinotecan—lung cancer	6.01e-05	0.000594	CcSEcCtD
Emtricitabine—Abdominal pain—Irinotecan—lung cancer	6.01e-05	0.000594	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—lung cancer	5.97e-05	0.000591	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—lung cancer	5.96e-05	0.00059	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Cisplatin—lung cancer	5.96e-05	0.000589	CcSEcCtD
Emtricitabine—Anaemia—Docetaxel—lung cancer	5.95e-05	0.000589	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—lung cancer	5.94e-05	0.000587	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—lung cancer	5.94e-05	0.000587	CcSEcCtD
Emtricitabine—Depression—Methotrexate—lung cancer	5.92e-05	0.000586	CcSEcCtD
Emtricitabine—Pain—Cisplatin—lung cancer	5.9e-05	0.000584	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—lung cancer	5.88e-05	0.000582	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—lung cancer	5.88e-05	0.000582	CcSEcCtD
Emtricitabine—Vomiting—Vinorelbine—lung cancer	5.86e-05	0.00058	CcSEcCtD
Emtricitabine—Body temperature increased—Gemcitabine—lung cancer	5.85e-05	0.000579	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—lung cancer	5.83e-05	0.000577	CcSEcCtD
Emtricitabine—Rash—Vinorelbine—lung cancer	5.81e-05	0.000575	CcSEcCtD
Emtricitabine—Dermatitis—Vinorelbine—lung cancer	5.8e-05	0.000574	CcSEcCtD
Emtricitabine—Headache—Vinorelbine—lung cancer	5.77e-05	0.000571	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—lung cancer	5.68e-05	0.000562	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—lung cancer	5.66e-05	0.00056	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—lung cancer	5.65e-05	0.000559	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Paclitaxel—lung cancer	5.65e-05	0.000559	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—lung cancer	5.63e-05	0.000558	CcSEcCtD
Emtricitabine—Cough—Docetaxel—lung cancer	5.62e-05	0.000556	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—lung cancer	5.61e-05	0.000556	CcSEcCtD
Emtricitabine—Insomnia—Paclitaxel—lung cancer	5.6e-05	0.000555	CcSEcCtD
Emtricitabine—Hypersensitivity—Irinotecan—lung cancer	5.6e-05	0.000554	CcSEcCtD
Emtricitabine—Paraesthesia—Paclitaxel—lung cancer	5.56e-05	0.000551	CcSEcCtD
Emtricitabine—Dyspnoea—Paclitaxel—lung cancer	5.52e-05	0.000547	CcSEcCtD
Emtricitabine—Arthralgia—Docetaxel—lung cancer	5.48e-05	0.000542	CcSEcCtD
Emtricitabine—Myalgia—Docetaxel—lung cancer	5.48e-05	0.000542	CcSEcCtD
Emtricitabine—Nausea—Vinorelbine—lung cancer	5.47e-05	0.000542	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—lung cancer	5.46e-05	0.00054	CcSEcCtD
Emtricitabine—Dyspepsia—Paclitaxel—lung cancer	5.45e-05	0.00054	CcSEcCtD
Emtricitabine—Body temperature increased—Cisplatin—lung cancer	5.45e-05	0.00054	CcSEcCtD
Emtricitabine—Asthenia—Irinotecan—lung cancer	5.45e-05	0.000539	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—lung cancer	5.45e-05	0.000539	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.44e-05	0.000538	CcSEcCtD
Emtricitabine—Pain—Etoposide—lung cancer	5.4e-05	0.000535	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—lung cancer	5.39e-05	0.000533	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—lung cancer	5.36e-05	0.00053	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Paclitaxel—lung cancer	5.35e-05	0.000529	CcSEcCtD
Emtricitabine—Fatigue—Paclitaxel—lung cancer	5.34e-05	0.000529	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—lung cancer	5.33e-05	0.000527	CcSEcCtD
Emtricitabine—Asthenia—Gemcitabine—lung cancer	5.31e-05	0.000526	CcSEcCtD
Emtricitabine—Pain—Paclitaxel—lung cancer	5.3e-05	0.000524	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—lung cancer	5.29e-05	0.000523	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—lung cancer	5.26e-05	0.000521	CcSEcCtD
Emtricitabine—Pruritus—Gemcitabine—lung cancer	5.24e-05	0.000518	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—lung cancer	5.22e-05	0.000517	CcSEcCtD
Emtricitabine—Infection—Docetaxel—lung cancer	5.22e-05	0.000516	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—lung cancer	5.22e-05	0.000516	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—lung cancer	5.2e-05	0.000515	CcSEcCtD
Emtricitabine—Diarrhoea—Irinotecan—lung cancer	5.2e-05	0.000514	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—lung cancer	5.17e-05	0.000512	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—lung cancer	5.17e-05	0.000511	CcSEcCtD
Emtricitabine—Nervous system disorder—Docetaxel—lung cancer	5.15e-05	0.00051	CcSEcCtD
Emtricitabine—Thrombocytopenia—Docetaxel—lung cancer	5.14e-05	0.000509	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—lung cancer	5.14e-05	0.000509	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—lung cancer	5.14e-05	0.000509	CcSEcCtD
Emtricitabine—Skin disorder—Docetaxel—lung cancer	5.1e-05	0.000505	CcSEcCtD
Emtricitabine—Hypersensitivity—Cisplatin—lung cancer	5.08e-05	0.000503	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Paclitaxel—lung cancer	5.07e-05	0.000501	CcSEcCtD
Emtricitabine—Diarrhoea—Gemcitabine—lung cancer	5.06e-05	0.000501	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—lung cancer	5.05e-05	0.0005	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—lung cancer	5.04e-05	0.000499	CcSEcCtD
Emtricitabine—Dizziness—Irinotecan—lung cancer	5.02e-05	0.000497	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—lung cancer	5.02e-05	0.000497	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—lung cancer	5e-05	0.000494	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—lung cancer	5e-05	0.000494	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—lung cancer	5e-05	0.000494	CcSEcCtD
Emtricitabine—Asthenia—Cisplatin—lung cancer	4.95e-05	0.00049	CcSEcCtD
Emtricitabine—Urticaria—Paclitaxel—lung cancer	4.92e-05	0.000487	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—lung cancer	4.9e-05	0.000485	CcSEcCtD
Emtricitabine—Abdominal pain—Paclitaxel—lung cancer	4.9e-05	0.000485	CcSEcCtD
Emtricitabine—Body temperature increased—Paclitaxel—lung cancer	4.9e-05	0.000485	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—lung cancer	4.86e-05	0.000481	CcSEcCtD
Emtricitabine—Vomiting—Irinotecan—lung cancer	4.83e-05	0.000478	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—lung cancer	4.82e-05	0.000477	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—lung cancer	4.81e-05	0.000476	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—lung cancer	4.8e-05	0.000475	CcSEcCtD
Emtricitabine—Rash—Irinotecan—lung cancer	4.79e-05	0.000474	CcSEcCtD
Emtricitabine—Dermatitis—Irinotecan—lung cancer	4.79e-05	0.000474	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Docetaxel—lung cancer	4.79e-05	0.000474	CcSEcCtD
Emtricitabine—Headache—Irinotecan—lung cancer	4.76e-05	0.000471	CcSEcCtD
Emtricitabine—Insomnia—Docetaxel—lung cancer	4.75e-05	0.00047	CcSEcCtD
Emtricitabine—Diarrhoea—Cisplatin—lung cancer	4.72e-05	0.000467	CcSEcCtD
Emtricitabine—Paraesthesia—Docetaxel—lung cancer	4.72e-05	0.000467	CcSEcCtD
Emtricitabine—Vomiting—Gemcitabine—lung cancer	4.71e-05	0.000466	CcSEcCtD
Emtricitabine—Dyspnoea—Docetaxel—lung cancer	4.68e-05	0.000463	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—lung cancer	4.67e-05	0.000462	CcSEcCtD
Emtricitabine—Rash—Gemcitabine—lung cancer	4.67e-05	0.000462	CcSEcCtD
Emtricitabine—Dermatitis—Gemcitabine—lung cancer	4.66e-05	0.000461	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—lung cancer	4.66e-05	0.000461	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—lung cancer	4.64e-05	0.000459	CcSEcCtD
Emtricitabine—Headache—Gemcitabine—lung cancer	4.64e-05	0.000459	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—lung cancer	4.63e-05	0.000458	CcSEcCtD
Emtricitabine—Dyspepsia—Docetaxel—lung cancer	4.62e-05	0.000458	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—lung cancer	4.61e-05	0.000457	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—lung cancer	4.58e-05	0.000453	CcSEcCtD
Emtricitabine—Hypersensitivity—Paclitaxel—lung cancer	4.57e-05	0.000452	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—lung cancer	4.56e-05	0.000451	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Docetaxel—lung cancer	4.53e-05	0.000449	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—lung cancer	4.53e-05	0.000449	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—lung cancer	4.53e-05	0.000449	CcSEcCtD
Emtricitabine—Fatigue—Docetaxel—lung cancer	4.53e-05	0.000448	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—lung cancer	4.52e-05	0.000448	CcSEcCtD
Emtricitabine—Nausea—Irinotecan—lung cancer	4.51e-05	0.000447	CcSEcCtD
Emtricitabine—Pain—Docetaxel—lung cancer	4.49e-05	0.000444	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—lung cancer	4.49e-05	0.000444	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—lung cancer	4.47e-05	0.000442	CcSEcCtD
Emtricitabine—Asthenia—Paclitaxel—lung cancer	4.45e-05	0.00044	CcSEcCtD
Emtricitabine—Nausea—Gemcitabine—lung cancer	4.4e-05	0.000435	CcSEcCtD
Emtricitabine—Vomiting—Cisplatin—lung cancer	4.39e-05	0.000434	CcSEcCtD
Emtricitabine—Pruritus—Paclitaxel—lung cancer	4.38e-05	0.000434	CcSEcCtD
Emtricitabine—Rash—Cisplatin—lung cancer	4.35e-05	0.00043	CcSEcCtD
Emtricitabine—Dermatitis—Cisplatin—lung cancer	4.35e-05	0.00043	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—lung cancer	4.32e-05	0.000428	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Docetaxel—lung cancer	4.3e-05	0.000425	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—lung cancer	4.29e-05	0.000424	CcSEcCtD
Emtricitabine—Diarrhoea—Paclitaxel—lung cancer	4.24e-05	0.00042	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—lung cancer	4.18e-05	0.000414	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—lung cancer	4.17e-05	0.000412	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—lung cancer	4.16e-05	0.000412	CcSEcCtD
Emtricitabine—Abdominal pain—Docetaxel—lung cancer	4.15e-05	0.000411	CcSEcCtD
Emtricitabine—Body temperature increased—Docetaxel—lung cancer	4.15e-05	0.000411	CcSEcCtD
Emtricitabine—Dizziness—Paclitaxel—lung cancer	4.1e-05	0.000406	CcSEcCtD
Emtricitabine—Nausea—Cisplatin—lung cancer	4.1e-05	0.000406	CcSEcCtD
Emtricitabine—Cough—Methotrexate—lung cancer	4.05e-05	0.000401	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—lung cancer	4.04e-05	0.0004	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—lung cancer	4.02e-05	0.000398	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—lung cancer	4.02e-05	0.000397	CcSEcCtD
Emtricitabine—Rash—Etoposide—lung cancer	3.99e-05	0.000394	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—lung cancer	3.98e-05	0.000394	CcSEcCtD
Emtricitabine—Headache—Etoposide—lung cancer	3.96e-05	0.000392	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—lung cancer	3.95e-05	0.000391	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—lung cancer	3.95e-05	0.000391	CcSEcCtD
Emtricitabine—Vomiting—Paclitaxel—lung cancer	3.94e-05	0.00039	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.92e-05	0.000388	CcSEcCtD
Emtricitabine—Rash—Paclitaxel—lung cancer	3.91e-05	0.000387	CcSEcCtD
Emtricitabine—Dermatitis—Paclitaxel—lung cancer	3.9e-05	0.000386	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—lung cancer	3.89e-05	0.000384	CcSEcCtD
Emtricitabine—Headache—Paclitaxel—lung cancer	3.88e-05	0.000384	CcSEcCtD
Emtricitabine—Hypersensitivity—Docetaxel—lung cancer	3.87e-05	0.000383	CcSEcCtD
Emtricitabine—Asthenia—Docetaxel—lung cancer	3.77e-05	0.000373	CcSEcCtD
Emtricitabine—Infection—Methotrexate—lung cancer	3.76e-05	0.000372	CcSEcCtD
Emtricitabine—Nausea—Etoposide—lung cancer	3.75e-05	0.000372	CcSEcCtD
Emtricitabine—Pruritus—Docetaxel—lung cancer	3.72e-05	0.000368	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—lung cancer	3.71e-05	0.000367	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—lung cancer	3.71e-05	0.000367	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—lung cancer	3.71e-05	0.000367	CcSEcCtD
Emtricitabine—Nausea—Paclitaxel—lung cancer	3.68e-05	0.000364	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—lung cancer	3.68e-05	0.000364	CcSEcCtD
Emtricitabine—Diarrhoea—Docetaxel—lung cancer	3.59e-05	0.000356	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—lung cancer	3.5e-05	0.000347	CcSEcCtD
Emtricitabine—Dizziness—Docetaxel—lung cancer	3.47e-05	0.000344	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—lung cancer	3.45e-05	0.000341	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—lung cancer	3.42e-05	0.000339	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—lung cancer	3.42e-05	0.000338	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—lung cancer	3.42e-05	0.000338	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—lung cancer	3.41e-05	0.000337	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—lung cancer	3.4e-05	0.000336	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.4e-05	0.000336	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—lung cancer	3.38e-05	0.000334	CcSEcCtD
Emtricitabine—Vomiting—Docetaxel—lung cancer	3.34e-05	0.00033	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—lung cancer	3.33e-05	0.00033	CcSEcCtD
Emtricitabine—Rash—Docetaxel—lung cancer	3.31e-05	0.000328	CcSEcCtD
Emtricitabine—Dermatitis—Docetaxel—lung cancer	3.31e-05	0.000327	CcSEcCtD
Emtricitabine—Headache—Docetaxel—lung cancer	3.29e-05	0.000326	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—lung cancer	3.27e-05	0.000323	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—lung cancer	3.26e-05	0.000323	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—lung cancer	3.26e-05	0.000322	CcSEcCtD
Emtricitabine—Pain—Methotrexate—lung cancer	3.24e-05	0.00032	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—lung cancer	3.21e-05	0.000318	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—lung cancer	3.21e-05	0.000318	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—lung cancer	3.18e-05	0.000315	CcSEcCtD
Emtricitabine—Nausea—Docetaxel—lung cancer	3.12e-05	0.000309	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—lung cancer	3.1e-05	0.000306	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—lung cancer	3.01e-05	0.000298	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—lung cancer	2.99e-05	0.000296	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—lung cancer	2.99e-05	0.000296	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.99e-05	0.000296	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—lung cancer	2.96e-05	0.000293	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—lung cancer	2.94e-05	0.000291	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—lung cancer	2.92e-05	0.000289	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—lung cancer	2.89e-05	0.000286	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—lung cancer	2.83e-05	0.00028	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—lung cancer	2.83e-05	0.00028	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—lung cancer	2.8e-05	0.000277	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—lung cancer	2.79e-05	0.000276	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—lung cancer	2.72e-05	0.000269	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—lung cancer	2.68e-05	0.000265	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—lung cancer	2.68e-05	0.000265	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—lung cancer	2.6e-05	0.000258	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—lung cancer	2.59e-05	0.000256	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—lung cancer	2.59e-05	0.000256	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—lung cancer	2.59e-05	0.000256	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—lung cancer	2.5e-05	0.000248	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—lung cancer	2.42e-05	0.000239	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—lung cancer	2.41e-05	0.000238	CcSEcCtD
Emtricitabine—Rash—Methotrexate—lung cancer	2.39e-05	0.000236	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—lung cancer	2.38e-05	0.000236	CcSEcCtD
Emtricitabine—Headache—Methotrexate—lung cancer	2.37e-05	0.000235	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—lung cancer	2.35e-05	0.000233	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—lung cancer	2.32e-05	0.00023	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—lung cancer	2.25e-05	0.000223	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—lung cancer	2.24e-05	0.000222	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—lung cancer	2.17e-05	0.000215	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—lung cancer	2.08e-05	0.000206	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—lung cancer	2.07e-05	0.000205	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—lung cancer	2.06e-05	0.000204	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—lung cancer	2.05e-05	0.000203	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—lung cancer	1.95e-05	0.000193	CcSEcCtD
